Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Root-Cause Treatment Lab work identifies insulin resistance, inflammation, thyroid issues, hormone imbalances and treats them alongside the medication
These consequences tend to occur late in the stress response cycle, but once they do show up, major disruptions to the cardionomic system follow
Statins reduce LDL by 30 to 60%
Source data for 82% of Wegovy pill new-to-brand (NBRx) starts year-to-date (YTD) 2026 is IQVIA LRx, YTD based on week ending January 9, 2026 through May 15, 2026, with "new to GLP-1" based on 12 months look back for any other (obesity or diabetes) GLP-1 medicine (not including compounded products)
US$ 25.94
US$ 20.94
US$ 26.89
